Regiospecific Intestinal Absorption of the HIV Protease Inhibitor L-735,524 in Beagle Dogs
暂无分享,去创建一个
Gloria Kwei | I. Chen | G. Kwei | Drazen Ostovic | Linda B. Novak | Lisa A. Hettrick | Elisabeth R. Reiss | Alice E. Loper | Chung Y. Lui | Raymond J. Higgins | I-Wu Chen | J. H. Lin | D. Ostovic | L. Novak | A. Loper | L. Hettrick | C. Lui | R. Higgins | Juinn H. Lin
[1] J. Wagner,et al. pH-Related Changes in the Absorption of Dipyridamole in the Elderly , 2004, Pharmaceutical Research.
[2] J. Lin,et al. High-performance liquid chromatographic determination of a potent and selective HIV protease inhibitor (L-735,524) in rat, dog and monkey plasma. , 1995, Journal of chromatography. B, Biomedical applications.
[3] P. Darke,et al. L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[4] Jerome J. Schentag,et al. Increased gastric pH and the bioavailability of fluconazole and ketoconazole. , 1991, Annals of internal medicine.
[5] G. Amidon,et al. Comparison of gastrointestinal pH in dogs and humans: implications on the use of the beagle dog as a model for oral absorption in humans. , 1986, Journal of pharmaceutical sciences.
[6] D. Wingate. Comparative physiology of the vertebrate digestive system , 1989 .
[7] Jerome J. Schentag,et al. Effects of ranitidine and sucralfate on ketoconazole bioavailability , 1991, Antimicrobial Agents and Chemotherapy.